デフォルト表紙
市場調査レポート
商品コード
1552522

皮下ドラッグデリバリーデバイス市場、規模、シェア、動向、産業分析レポート:製品タイプ別、使用性別、流通チャネル別、地域別- 市場予測、2024年~2032年

Subcutaneous Drug Delivery Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type, By Usability, By Distribution Channel, and By Region - Market Forecast, 2024-2032


出版日
ページ情報
英文 117 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
皮下ドラッグデリバリーデバイス市場、規模、シェア、動向、産業分析レポート:製品タイプ別、使用性別、流通チャネル別、地域別- 市場予測、2024年~2032年
出版日: 2024年08月01日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、皮下ドラッグデリバリーデバイスの世界市場規模は2032年までに535億米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

皮下ドラッグデリバリーデバイス市場には、インスリンペン、自動注射器、輸液ポンプなど、皮下に薬剤を投与するために設計された製品が含まれます。これらのデバイスは、慢性疾患に対する制御された患者に優しい薬物送達を促進し、服薬アドヒアランスと治療成績を向上させます。

世界の皮下ドラッグデリバリーデバイス市場は、いくつかの重要な要因によって力強い成長を遂げています。糖尿病や関節リウマチなど、頻繁な薬物投与を必要とする慢性疾患の有病率の増加が、皮下投与ソリューションの需要を大幅に押し上げています。さらに、デバイス設計の技術的進歩や統合モニタリングシステムを備えたスマートデバイスの開発が、患者のコンプライアンスと利便性を高めています。

また、正確で調節可能な投与レジメンを必要とする個別化医療への新たな動向も、市場拡大に寄与しています。さらに、在宅ヘルスケアや薬剤の自己投与が重視されるようになっていることも、皮下ドラッグデリバリーデバイスの採用に拍車をかけています。これらの要因は、デバイス技術の革新と相まって、市場の軌道を形成し続けると予想されます。

皮下ドラッグデリバリーデバイス市場レポートハイライト

製品タイプ別では、自動注射器が皮下ドラッグデリバリーデバイス市場を独占しています。これは、その使いやすさ、利便性、頻繁な自己投与を必要とする慢性疾患の有病率の増加が背景にあります。

使用性では、ディスポーザブル(使い捨て)デバイスが、その利便性、使いやすさ、患者やヘルスケアプロバイダーにアピールする感染リスクの低減により、市場で圧倒的な地位を占めています。

流通チャネルでは、病院薬局が確立されたインフラと定期的な投薬が必要な慢性疾患患者の多さから、依然として圧倒的な地位を占めています。

北米が市場を独占しているのに対し、アジア太平洋地域は予測期間中に最も高い成長率を示すと予想されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の皮下ドラッグデリバリーデバイス市場の洞察

  • 市場スナップショット
  • 皮下ドラッグデリバリーデバイス市場力学
    • 促進要因と機会
      • 統合モニタリング機能を備えたスマートデバイスの台頭が市場の成長を牽引
      • 在宅ヘルスケアソリューションの需要増加が市場規模を押し上げている
    • 抑制要因と課題
      • 高度なデバイスの高コスト
  • PESTEL分析
  • 皮下ドラッグデリバリーデバイスの市場動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の皮下ドラッグデリバリーデバイス市場:製品タイプ別

  • 主な調査結果
  • イントロダクション
  • 自動注射器
  • プレフィルドシリンジ
  • ペン型注射器
  • ウェアラブルインジェクター
  • 針なし注射器

第6章 世界の皮下ドラッグデリバリーデバイス市場:使用性別

  • 主な調査結果
  • イントロダクション
  • 使い捨てデバイス
  • 再利用可能なデバイス

第7章 世界の皮下ドラッグデリバリーデバイス市場:流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 世界の皮下ドラッグデリバリーデバイス市場:地域別

  • 主な調査結果
  • イントロダクション
  • 北米
    • 北米:製品タイプ別、2019年~2032年
    • 北米:使用性別、2019年~2032年
    • 北米:流通チャネル別、2019年~2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州:製品タイプ別、2019年~2032年
    • 欧州:使用性別、2019年~2032年
    • 欧州:流通チャネル別、2019年~2032年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋:製品タイプ別、2019年~2032年
    • アジア太平洋:使用性別、2019年~2032年
    • アジア太平洋:流通チャネル別、2019年~2032年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ:製品タイプ別、2019年~2032年
    • 中東・アフリカ:使用性別、2019年~2032年
    • 中東・アフリカ:流通チャネル別、2019年~2032年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ:製品タイプ別、2019年~2032年
    • ラテンアメリカ:使用性別、2019年~2032年
    • ラテンアメリカ:流通チャネル別、2019年~2032年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • AbbVie
  • Medtronic
  • Novo Nordisk
  • Eli Lilly
  • Becton, Dickinson and Company(BD)
  • Johnson & Johnson
  • Insulet Corporation
  • Ypsomed
  • Sanofi
  • Roche
  • Bayer
  • Terumo Corporation
  • Pfizer
  • 3M
  • Dexcom
図表

List of Tables

  • Table 1 Global Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 2 Global Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 3 Global Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 4 North America: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 5 North America: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 6 North America: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 7 U.S.: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 8 U.S.: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 9 U.S.: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 10 Canada: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 11 Canada: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 12 Canada: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 13 Europe: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 14 Europe: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 15 Europe: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 16 UK: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 17 UK: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 18 UK: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 19 France: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 20 France: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 21 France: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 22 Germany: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 23 Germany: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 24 Germany: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 25 Italy: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 26 Italy: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 27 Italy: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 28 Spain: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 29 Spain: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 30 Spain: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 31 Netherlands: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 32 Netherlands: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 33 Netherlands: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 34 Russia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 35 Russia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 36 Russia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 37 Rest of Europe: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 38 Rest of Europe: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 39 Rest of Europe: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 40 Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 41 Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 42 Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 43 China: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 44 China: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 45 China: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 46 India: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 47 India: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 48 India: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 49 Malaysia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 50 Malaysia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 51 Malaysia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 52 Japan: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 53 Japan: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 54 Japan: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 55 Indonesia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 56 Indonesia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 57 Indonesia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 58 South Korea: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 59 South Korea: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 60 South Korea: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 61 Australia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 62 Australia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 63 Australia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 64 Rest of Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 65 Rest of Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 66 Rest of Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 67 Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 68 Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 69 Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 70 Saudi Arabia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 71 Saudi Arabia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 72 Saudi Arabia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 73 UAE: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 74 UAE: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 75 UAE: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 76 Israel: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 77 Israel: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 78 Israel: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 79 South Africa: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 80 South Africa: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 81 South Africa: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 82 Rest of Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 83 Rest of Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 84 Rest of Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 85 Latin America: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 86 Latin America: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 87 Latin America: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 88 Mexico: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 89 Mexico: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 90 Mexico: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 91 Brazil: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 92 Brazil: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 93 Brazil: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 94 Argentina: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 95 Argentina: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 96 Argentina: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • Table 97 Rest of Latin America: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • Table 98 Rest of Latin America: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • Table 99 Rest of Latin America: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
目次
Product Code: PM5035

The global subcutaneous drug delivery devices market size is expected to reach USD 53.50 billion by 2032, according to a new study by Polaris Market Research. The report "Subcutaneous Drug Delivery Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type (Auto-Injectors, Pre-filled Syringes, Pen Injectors, Wearable Injectors, and Needle Free Injectors), By Usability, By Distribution Channel, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The subcutaneous drug delivery devices market encompasses products designed for the administration of medication under the skin, such as insulin pens, auto-injectors, and infusion pumps. These devices facilitate controlled, patient-friendly drug delivery for chronic conditions, improving adherence and therapeutic outcomes.

The global subcutaneous drug delivery devices market is experiencing robust growth driven by several key factors. The increasing prevalence of chronic diseases such as diabetes and rheumatoid arthritis, which require frequent medication administration, is significantly boosting demand for subcutaneous delivery solutions. Additionally, technological advancements in device design and the development of smart devices with integrated monitoring systems are enhancing patient compliance and convenience.

The emerging trend toward personalized medicine, which necessitates precise and adjustable dosing regimens, is also contributing to the market expansion. Moreover, the growing emphasis on home healthcare and self-administration of medications is further fueling the adoption of subcutaneous drug delivery devices. These factors, coupled with innovations in device technology, are expected to continue shaping the market's trajectory.

Subcutaneous Drug Delivery Devices Market Report Highlights

Based on product type, the auto-injectors segment dominates the subcutaneous drug delivery devices market, driven by their ease of use, convenience, and the growing prevalence of chronic diseases that require frequent self-administration.

By usability, the disposable devices segment holds the dominant position in the market due to their convenience, ease of use, and reduced risk of infection, which appeals to patients and healthcare providers.

In terms of distribution channel, the hospital pharmacies segment remains the dominating segment due to their established infrastructure and the high volume of chronic disease patients requiring regular medication.

North America dominates the market, whereas Asia Pacific is expected to witness the highest growth rate during the forecast period.

Key players in the subcutaneous drug delivery devices market include AbbVie, Medtronic, Novo Nordisk, Eli Lilly, Becton, Dickinson and Company (BD), Johnson & Johnson, Insulet Corporation, Ypsomed, Sanofi, Roche, Bayer, Terumo Corporation, Pfizer, 3M, and Dexcom.

Polaris Market Research has segmented the subcutaneous drug delivery devices market report on the basis of product type, usability, distribution channel, and region.

Subcutaneous Drug Delivery Devices - Product Type Outlook (Revenue - USD Billion, 2019-2032)

  • Auto-Injectors
  • Pre-filled Syringes
  • Pen Injectors
  • Wearable Injectors
  • Needle Free Injectors

Subcutaneous Drug Delivery Devices - Usability Outlook (Revenue - USD Billion, 2019-2032)

  • Disposable Devices
  • Reusable Devices

Subcutaneous Drug Delivery Devices - Distribution Channel Outlook (Revenue - USD Billion, 2019-2032)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Subcutaneous Drug Delivery Devices - Regional Outlook (Revenue - USD Billion, 2019-2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Subcutaneous Drug Delivery Devices Market Insights

  • 4.1. Subcutaneous Drug Delivery Devices Market - Market Snapshot
  • 4.2. Subcutaneous Drug Delivery Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rise of Smart Devices with Integrated Monitoring Are Driving Market Growth
      • 4.2.1.2. Growing Demand for Home Healthcare Solutions is Propelling Market Size
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Costs of Advanced Devices
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Subcutaneous Drug Delivery Devices Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Subcutaneous Drug Delivery Devices Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
  • 5.3. Auto-Injectors
    • 5.3.1. Global Subcutaneous Drug Delivery Devices Market, by Auto-Injectors, by Region, 2019-2032 (USD billion)
  • 5.4. Pre-filled Syringes
    • 5.4.1. Global Subcutaneous Drug Delivery Devices Market, by Pre-filled Syringes, by Region, 2019-2032 (USD billion)
  • 5.5. Pen Injectors
    • 5.5.1. Global Subcutaneous Drug Delivery Devices Market, by Pen Injectors, by Region, 2019-2032 (USD billion)
  • 5.6. Wearable Injectors
    • 5.6.1. Global Subcutaneous Drug Delivery Devices Market, by Wearable Injectors, by Region, 2019-2032 (USD billion)
  • 5.7. Needle Free Injectors
    • 5.7.1. Global Subcutaneous Drug Delivery Devices Market, by Needle Free Injectors, by Region, 2019-2032 (USD billion)

6. Global Subcutaneous Drug Delivery Devices Market, by Usability

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
  • 6.3. Disposable Devices
    • 6.3.1. Global Subcutaneous Drug Delivery Devices Market, by Disposable Devices, by Region, 2019-2032 (USD billion)
  • 6.4. Reusable Devices
    • 6.4.1. Global Subcutaneous Drug Delivery Devices Market, by Reusable Devices, by Region, 2019-2032 (USD billion)

7. Global Subcutaneous Drug Delivery Devices Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Subcutaneous Drug Delivery Devices Market, by Hospital Pharmacies, by Region, 2019-2032 (USD billion)
      • 7.3.1.1.
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Subcutaneous Drug Delivery Devices Market, by Retail Pharmacies, by Region, 2019-2032 (USD billion)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Subcutaneous Drug Delivery Devices Market, by Online Pharmacies, by Region, 2019-2032 (USD billion)

8. Global Subcutaneous Drug Delivery Devices Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Subcutaneous Drug Delivery Devices Market Assessment, By Geography, 2019-2032 (USD billion)
  • 8.3. Subcutaneous Drug Delivery Devices Market - North America
    • 8.3.1. North America: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
    • 8.3.2. North America: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
    • 8.3.3. North America: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.3.4. Subcutaneous Drug Delivery Devices Market - U.S.
      • 8.3.4.1. U.S.: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.3.4.2. U.S.: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.3.4.3. U.S.: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.3.5. Subcutaneous Drug Delivery Devices Market - Canada
      • 8.3.5.1. Canada: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.3.5.2. Canada: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.3.5.3. Canada: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • 8.4. Subcutaneous Drug Delivery Devices Market - Europe
    • 8.4.1. Europe: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
    • 8.4.2. Europe: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
    • 8.4.3. Europe: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.4. Subcutaneous Drug Delivery Devices Market - UK
      • 8.4.4.1. UK: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.4.2. UK: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.4.3. UK: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.5. Subcutaneous Drug Delivery Devices Market - France
      • 8.4.5.1. France: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.5.2. France: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.5.3. France: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.6. Subcutaneous Drug Delivery Devices Market - Germany
      • 8.4.6.1. Germany: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.6.2. Germany: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.6.3. Germany: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.7. Subcutaneous Drug Delivery Devices Market - Italy
      • 8.4.7.1. Italy: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.7.2. Italy: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.7.3. Italy: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.8. Subcutaneous Drug Delivery Devices Market - Spain
      • 8.4.8.1. Spain: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.8.2. Spain: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.8.3. Spain: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.9. Subcutaneous Drug Delivery Devices Market - Netherlands
      • 8.4.9.1. Netherlands: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.9.2. Netherlands: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.9.3. Netherlands: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.10. Subcutaneous Drug Delivery Devices Market - Russia
      • 8.4.10.1. Russia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.10.2. Russia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.10.3. Russia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.4.11. Subcutaneous Drug Delivery Devices Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.4.11.2. Rest of Europe: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.4.11.3. Rest of Europe: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • 8.5. Subcutaneous Drug Delivery Devices Market - Asia Pacific
    • 8.5.1. Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
    • 8.5.2. Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
    • 8.5.3. Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.4. Subcutaneous Drug Delivery Devices Market - China
      • 8.5.4.1. China: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.4.2. China: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.4.3. China: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.5. Subcutaneous Drug Delivery Devices Market - India
      • 8.5.5.1. India: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.5.2. India: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.5.3. India: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.6. Subcutaneous Drug Delivery Devices Market - Malaysia
      • 8.5.6.1. Malaysia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.6.2. Malaysia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.6.3. Malaysia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.7. Subcutaneous Drug Delivery Devices Market - Japan
      • 8.5.7.1. Japan: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.7.2. Japan: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.7.3. Japan: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.8. Subcutaneous Drug Delivery Devices Market - Indonesia
      • 8.5.8.1. Indonesia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.8.2. Indonesia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.8.3. Indonesia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.9. Subcutaneous Drug Delivery Devices Market - South Korea
      • 8.5.9.1. South Korea: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.9.2. South Korea: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.9.3. South Korea: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.10. Subcutaneous Drug Delivery Devices Market - Australia
      • 8.5.10.1. Australia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.10.2. Australia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.10.3. Australia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.5.11. Subcutaneous Drug Delivery Devices Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.5.11.2. Rest of Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.5.11.3. Rest of Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • 8.6. Subcutaneous Drug Delivery Devices Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
    • 8.6.2. Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
    • 8.6.3. Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.6.4. Subcutaneous Drug Delivery Devices Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.6.4.2. Saudi Arabia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.6.4.3. Saudi Arabia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.6.5. Subcutaneous Drug Delivery Devices Market - UAE
      • 8.6.5.1. UAE: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.6.5.2. UAE: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.6.5.3. UAE: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.6.6. Subcutaneous Drug Delivery Devices Market - Israel
      • 8.6.6.1. Israel: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.6.6.2. Israel: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.6.6.3. Israel: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.6.7. Subcutaneous Drug Delivery Devices Market - South Africa
      • 8.6.7.1. South Africa: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.6.7.2. South Africa: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.6.7.3. South Africa: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.6.8. Subcutaneous Drug Delivery Devices Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.6.8.2. Rest of Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.6.8.3. Rest of Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
  • 8.7. Subcutaneous Drug Delivery Devices Market - Latin America
    • 8.7.1. Latin America: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
    • 8.7.2. Latin America: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
    • 8.7.3. Latin America: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.7.4. Subcutaneous Drug Delivery Devices Market - Mexico
      • 8.7.4.1. Mexico: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.7.4.2. Mexico: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.7.4.3. Mexico: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.7.5. Subcutaneous Drug Delivery Devices Market - Brazil
      • 8.7.5.1. Brazil: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.7.5.2. Brazil: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.7.5.3. Brazil: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.7.6. Subcutaneous Drug Delivery Devices Market - Argentina
      • 8.7.6.1. Argentina: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.7.6.2. Argentina: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.7.6.3. Argentina: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
    • 8.7.7. Subcutaneous Drug Delivery Devices Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
      • 8.7.7.2. Rest of Latin America: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
      • 8.7.7.3. Rest of Latin America: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Medtronic
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Novo Nordisk
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Eli Lilly
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Becton, Dickinson and Company (BD)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Johnson & Johnson
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Insulet Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Ypsomed
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sanofi
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Roche
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Bayer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Terumo Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Pfizer
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. 3M
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Dexcom
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development